Blogs Mechanism Identified for Drug Resistance in Glioblastoma Brain Tumors Published November 02, 2022 Related News News Mention Dr. Strickler on the Development of Telisotuzumab Adizutecan in MET-Amplified Gastric Cancer January 06, 2025 OncLive News Mention Dr. Julia Visgauss, MD, Keynote Speaker at Sarcoma Strong Foundation Gala: Advancing Research in Chondrosarcoma Metastasis March 13, 2025 Duke Orthopaedic Surgery Related News News Mention Dr. Strickler on the Development of Telisotuzumab Adizutecan in MET-Amplified Gastric Cancer January 06, 2025 OncLive News Mention Dr. Julia Visgauss, MD, Keynote Speaker at Sarcoma Strong Foundation Gala: Advancing Research in Chondrosarcoma Metastasis March 13, 2025 Duke Orthopaedic Surgery
News Mention Dr. Strickler on the Development of Telisotuzumab Adizutecan in MET-Amplified Gastric Cancer January 06, 2025 OncLive
News Mention Dr. Julia Visgauss, MD, Keynote Speaker at Sarcoma Strong Foundation Gala: Advancing Research in Chondrosarcoma Metastasis March 13, 2025 Duke Orthopaedic Surgery
News Mention Dr. Strickler on the Development of Telisotuzumab Adizutecan in MET-Amplified Gastric Cancer January 06, 2025 OncLive
News Mention Dr. Julia Visgauss, MD, Keynote Speaker at Sarcoma Strong Foundation Gala: Advancing Research in Chondrosarcoma Metastasis March 13, 2025 Duke Orthopaedic Surgery